Table 4.
Costs and QALY estimates for the three scenarios considered in the cost-utility analysis
| Intervention (N = 600) | Control (N = 663) | p-value | |||
|---|---|---|---|---|---|
| Mean | Sd | Mean | Sd | P | |
| Scenario 1: 3 months | |||||
| Difference in yearly patient costs between T3 and T0 (public healthcare perspective, [13] Euros 2015) | −122.63 | 747.03 | −113.29 | 828.04 | 0.01 |
| Difference in yearly patient costs between T3 and T0 (societal perspective, [6] Euros 2015) | −95.17 | 660.94 | −95.82 | 741.32 | 0.01 |
| Difference1 in QALYs between T3 and T0 [39] | 0.02 | 0.10 | 0.01 | 0.10 | 0.86 |
| Scenario 2: 6 months | |||||
| Difference in yearly patient costs between T6 and T0 (public healthcare, [13] Euros 2015) | −154.84 | 846.47 | −113.29 | 828.04 | 0.01 |
| Difference in yearly patient costs between T6 and T0 (societal perspective, [6] Euros 2015) | −115.93 | 741.45 | −95.82 | 741.32 | 0.01 |
| Difference in QALY s between T6 and T0 [39] | 0.03 | 0.12 | 0.01 | 0.10 | 0.01 |
| Scenario 3: 9 months | |||||
| Difference in yearly patient costs between T9 and T0 (public healthcare perspective, [13] Euros 2015) | −207.04 | 828.88 | −113.29 | 828.04 | 0.01 |
| Difference in yearly patient costs between T9 and T0 (societal perspective [6] Euros 2015) | −158.56 | 729.97 | −96.12 | 741.37 | 0.01 |
| Difference in QALYs between T9 and T0 [39] | 0.04 | 0.11 | 0.01 | 0.10 | 0.01 |